Cargando…

CD2 Immunobiology

The glycoprotein CD2 is a costimulatory receptor expressed mainly on T and NK cells that binds to LFA3, a cell surface protein expressed on e.g., antigen-presenting cells. CD2 has an important role in the formation and organization of the immunological synapse that is formed between T cells and anti...

Descripción completa

Detalles Bibliográficos
Autores principales: Binder, Christian, Cvetkovski, Filip, Sellberg, Felix, Berg, Stefan, Paternina Visbal, Horacio, Sachs, David H., Berglund, Erik, Berglund, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7295915/
https://www.ncbi.nlm.nih.gov/pubmed/32582179
http://dx.doi.org/10.3389/fimmu.2020.01090
_version_ 1783546737782161408
author Binder, Christian
Cvetkovski, Filip
Sellberg, Felix
Berg, Stefan
Paternina Visbal, Horacio
Sachs, David H.
Berglund, Erik
Berglund, David
author_facet Binder, Christian
Cvetkovski, Filip
Sellberg, Felix
Berg, Stefan
Paternina Visbal, Horacio
Sachs, David H.
Berglund, Erik
Berglund, David
author_sort Binder, Christian
collection PubMed
description The glycoprotein CD2 is a costimulatory receptor expressed mainly on T and NK cells that binds to LFA3, a cell surface protein expressed on e.g., antigen-presenting cells. CD2 has an important role in the formation and organization of the immunological synapse that is formed between T cells and antigen-presenting cells upon cell-cell conjugation and associated intracellular signaling. CD2 expression is upregulated on memory T cells as well as activated T cells and plays an important role in activation of memory T cells despite the coexistence of several other costimulatory pathways. Anti-CD2 monoclonal antibodies have been shown to induce immune modulatory effects in vitro and clinical studies have proven the safety and efficacy of CD2-targeting biologics. Investigators have highlighted that the lack of attention to the CD2/LFA3 costimulatory pathway is a missed opportunity. Overall, CD2 is an attractive target for monoclonal antibodies intended for treatment of pathologies characterized by undesired T cell activation and offers an avenue to more selectively target memory T cells while favoring immune regulation.
format Online
Article
Text
id pubmed-7295915
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-72959152020-06-23 CD2 Immunobiology Binder, Christian Cvetkovski, Filip Sellberg, Felix Berg, Stefan Paternina Visbal, Horacio Sachs, David H. Berglund, Erik Berglund, David Front Immunol Immunology The glycoprotein CD2 is a costimulatory receptor expressed mainly on T and NK cells that binds to LFA3, a cell surface protein expressed on e.g., antigen-presenting cells. CD2 has an important role in the formation and organization of the immunological synapse that is formed between T cells and antigen-presenting cells upon cell-cell conjugation and associated intracellular signaling. CD2 expression is upregulated on memory T cells as well as activated T cells and plays an important role in activation of memory T cells despite the coexistence of several other costimulatory pathways. Anti-CD2 monoclonal antibodies have been shown to induce immune modulatory effects in vitro and clinical studies have proven the safety and efficacy of CD2-targeting biologics. Investigators have highlighted that the lack of attention to the CD2/LFA3 costimulatory pathway is a missed opportunity. Overall, CD2 is an attractive target for monoclonal antibodies intended for treatment of pathologies characterized by undesired T cell activation and offers an avenue to more selectively target memory T cells while favoring immune regulation. Frontiers Media S.A. 2020-06-09 /pmc/articles/PMC7295915/ /pubmed/32582179 http://dx.doi.org/10.3389/fimmu.2020.01090 Text en Copyright © 2020 Binder, Cvetkovski, Sellberg, Berg, Paternina Visbal, Sachs, Berglund and Berglund. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Binder, Christian
Cvetkovski, Filip
Sellberg, Felix
Berg, Stefan
Paternina Visbal, Horacio
Sachs, David H.
Berglund, Erik
Berglund, David
CD2 Immunobiology
title CD2 Immunobiology
title_full CD2 Immunobiology
title_fullStr CD2 Immunobiology
title_full_unstemmed CD2 Immunobiology
title_short CD2 Immunobiology
title_sort cd2 immunobiology
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7295915/
https://www.ncbi.nlm.nih.gov/pubmed/32582179
http://dx.doi.org/10.3389/fimmu.2020.01090
work_keys_str_mv AT binderchristian cd2immunobiology
AT cvetkovskifilip cd2immunobiology
AT sellbergfelix cd2immunobiology
AT bergstefan cd2immunobiology
AT paterninavisbalhoracio cd2immunobiology
AT sachsdavidh cd2immunobiology
AT berglunderik cd2immunobiology
AT berglunddavid cd2immunobiology